Cannabis And Heart Attack Paradox: New Study Reveals Better Outcomes For Weed Users

Zinger Key Points
  • The study uncovers a link between cannabis use and lower in-hospital mortality after heart attacks, defying conventional medical beliefs.
  • Cannabis users show reduced need for critical heart procedures, sparking curiosity about the plant's potential therapeutic effects.
  • Findings suggest cannabis may offer unexpected cardio-protective benefits, challenging the narrative around its impact on heart health.

A recent study spanning two decades reveals that cannabis users may experience better outcomes after heart attacks compared to non-users, challenging the long-held belief that cannabis could exacerbate heart problems.

The study, published in the Archives of Medical Science Atherosclerosis Diseases, analyzed data from over 9 million acute myocardial infarction (AMI) patients, identifying 117,641 cannabis users. The results indicated that cannabis users had lower odds of atrial fibrillation, ventricular fibrillation, cardiogenic shock and in-hospital mortality, presenting a potential shift in understanding the substance’s impact on heart health.

Cannabis Users Show Fewer Heart Complications

Contrary to common concerns linking cannabis with increased heart risks, the study suggests a paradox where users show a reduced likelihood of severe complications post-heart attack. This includes lower occurrences of procedures like percutaneous coronary interventions (PCI) and intra-aortic balloon pump (IABP) usage.

Read Also: Heavy Cannabis Use Linked To Higher Head And Neck Cancer Risk, New Study Finds

Interestingly, the study revealed that cannabis users were generally younger, which may influence the lower prevalence of concurrent comorbidities like hypertension and diabetes, which are prevalent in older populations. Despite the higher incidence of risky behaviors such as smoking and alcohol use among cannabis users, the study adjusted for these factors through propensity score matching and multivariate regression models, ensuring the results specifically highlighted the effects of cannabis.

Exploring the ‘Cannabis Paradox' In Heart Health

This study’s findings are particularly relevant as cannabis gains social acceptance and legal status in many regions. The observed “cannabis paradox” mirrors the “smoker's paradox,” where smokers unexpectedly show better short-term survival after AMI compared to non-smokers. Researchers hypothesize that activation of cannabinoid receptor type 2 (CB2) might offer cardioprotection, which could explain the improved outcomes among cannabis users.

However, the authors caution that despite these promising results, the potential underreporting of cannabis use and other limitations mean that further research is necessary. They advocate for more comprehensive studies to explore the intricate effects of cannabis on cardiovascular health, emphasizing the need for a nuanced understanding of its clinical and therapeutic implications.

Therapeutic Effects For Older Patients

Furthermore, the latest findings on cannabis users’ improved heart attack outcomes align with growing evidence of the plant’s therapeutic benefits, as seen in a recent study on older patients using cannabis for chronic pain conducted by Tilray Medical, a division of Tilray Brands, Inc. TLRY. Both studies highlight cannabis’s evolving role in enhancing health outcomes.

Read Next:

Photo: Benzinga edit of images by Robina Weermeijer and Paul Einerhand on Unsplash.

CCC banner https://www.benzinga.com/events/cannabis-conference/
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsHealth CareArchives of Medical Science Atherosclerosis Diseasesheart health and cannabis
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.